{"2409.01903": {"publish_time": "2024-09-03", "title": "A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management", "paper_summary": "Background: Medication review is a structured interview of the patient,\nperformed by the pharmacist and aimed at optimizing drug treatments. In\npractice, medication review is a long and cognitively-demanding task that\nrequires specific knowledge. Clinical practice guidelines have been proposed,\nbut their application is tedious. Methods: We designed ABiMed, a clinical\ndecision support system for medication reviews, based on the implementation of\nthe STOPP/START v2 guidelines and on the visual presentation of aggregated drug\nknowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39\ncommunity pharmacists during a randomized simulation trial, each pharmacist\nperforming a medication review for two fictitious patients without ABiMed, and\ntwo others with ABiMed. We recorded the problems identified by the pharmacists,\nthe interventions proposed, the response time, the perceived usability and the\ncomments. Pharmacists' medication reviews were compared to an expert-designed\ngold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant\ndrug-related problems during the medication review (p=1.1e-12) and proposed\nbetter interventions (p=9.8e-9), without needing more time (p=0.56). The System\nUsability Scale score is 82.7, which is ranked \"excellent\". In their comments,\npharmacists appreciated the visual aspect of ABiMed and its ability to compare\nthe current treatment with the proposed one. A multifactor analysis showed no\ndifference in the support offered by ABiMed according to the pharmacist's age\nor sex, in terms of percentage of problems identified or quality of the\nproposed interventions. Conclusions: The use of an intelligent and visual\nclinical decision support system can help pharmacists when they perform\nmedication reviews. Our main perspective is the validation of the system in\nclinical conditions.", "paper_summary_zh": "<paragraph>\u80cc\u666f\uff1a\u7528\u85e5\u5be9\u67e5\u662f\u7531\u85e5\u5e2b\u57f7\u884c\u7684\u4e00\u7a2e\u7d50\u69cb\u5316\u60a3\u8005\u8a2a\u8ac7\uff0c\u76ee\u7684\u5728\u65bc\u512a\u5316\u85e5\u7269\u6cbb\u7642\u3002\u5728\u5be6\u52d9\u4e0a\uff0c\u7528\u85e5\u5be9\u67e5\u662f\u4e00\u9805\u5197\u9577\u4e14\u8a8d\u77e5\u9700\u6c42\u9ad8\u7684\u4efb\u52d9\uff0c\u9700\u8981\u5177\u5099\u7279\u5b9a\u77e5\u8b58\u3002\u96d6\u7136\u5df2\u63d0\u51fa\u81e8\u5e8a\u5be6\u52d9\u6307\u5f15\uff0c\u4f46\u5176\u61c9\u7528\u5f88\u7e41\u7463\u3002\u65b9\u6cd5\uff1a\u6211\u5011\u6839\u64da STOPP/START v2 \u6307\u5f15\u7684\u5be6\u4f5c\uff0c\u4e26\u4f7f\u7528\u8868\u683c\u3001\u5716\u8868\u548c\u82b1\u5f62\u7b26\u865f\u8996\u89ba\u5316\u5448\u73fe\u5f59\u6574\u7684\u85e5\u7269\u77e5\u8b58\uff0c\u8a2d\u8a08\u4e86\u4e00\u5957\u7528\u85e5\u5be9\u67e5\u7684\u81e8\u5e8a\u6c7a\u7b56\u652f\u63f4\u7cfb\u7d71 ABiMed\u3002\u6211\u5011\u5728\u96a8\u6a5f\u6a21\u64ec\u8a66\u9a57\u4e2d\uff0c\u8b93 39 \u4f4d\u793e\u5340\u85e5\u5e2b\u8a55\u4f30 ABiMed\uff0c\u6bcf\u4f4d\u85e5\u5e2b\u91dd\u5c0d\u5169\u4f4d\u865b\u69cb\u60a3\u8005\u57f7\u884c\u7528\u85e5\u5be9\u67e5\uff0c\u5169\u6b21\u6c92\u6709\u4f7f\u7528 ABiMed\uff0c\u5169\u6b21\u4f7f\u7528 ABiMed\u3002\u6211\u5011\u8a18\u9304\u4e86\u85e5\u5e2b\u8b58\u5225\u51fa\u7684\u554f\u984c\u3001\u5efa\u8b70\u7684\u4ecb\u5165\u63aa\u65bd\u3001\u53cd\u61c9\u6642\u9593\u3001\u611f\u77e5\u53ef\u7528\u6027\u548c\u8a55\u8ad6\u3002\u5c07\u85e5\u5e2b\u7684\u7528\u85e5\u5be9\u67e5\u8207\u5c08\u5bb6\u8a2d\u8a08\u7684\u91d1\u6a19\u6e96\u9032\u884c\u6bd4\u8f03\u3002\u7d50\u679c\uff1a\u4f7f\u7528 ABiMed \u5f8c\uff0c\u85e5\u5e2b\u5728\u7528\u85e5\u5be9\u67e5\u671f\u9593\u767c\u73fe\u4e86\u591a 1.6 \u500d\u76f8\u95dc\u7684\u85e5\u7269\u76f8\u95dc\u554f\u984c\uff08p=1.1e-12\uff09\uff0c\u4e26\u63d0\u51fa\u66f4\u597d\u7684\u4ecb\u5165\u63aa\u65bd\uff08p=9.8e-9\uff09\uff0c\u800c\u7121\u9700\u82b1\u8cbb\u66f4\u591a\u6642\u9593\uff08p=0.56\uff09\u3002\u7cfb\u7d71\u53ef\u7528\u6027\u8a55\u5206\u70ba 82.7\uff0c\u88ab\u8a55\u70ba\u300c\u512a\u826f\u300d\u3002\u5728\u4ed6\u5011\u7684\u8a55\u8ad6\u4e2d\uff0c\u85e5\u5e2b\u8b9a\u8cde ABiMed \u7684\u8996\u89ba\u5316\u9762\u5411\uff0c\u4ee5\u53ca\u5b83\u6bd4\u8f03\u76ee\u524d\u6cbb\u7642\u8207\u5efa\u8b70\u6cbb\u7642\u7684\u80fd\u529b\u3002\u591a\u56e0\u7d20\u5206\u6790\u986f\u793a\uff0cABiMed \u63d0\u4f9b\u7684\u652f\u63f4\u5728\u85e5\u5e2b\u7684\u5e74\u9f61\u6216\u6027\u5225\u65b9\u9762\u6c92\u6709\u5dee\u7570\uff0c\u5c31\u8b58\u5225\u51fa\u7684\u554f\u984c\u767e\u5206\u6bd4\u6216\u5efa\u8b70\u4ecb\u5165\u63aa\u65bd\u7684\u54c1\u8cea\u800c\u8a00\u3002\u7d50\u8ad6\uff1a\u4f7f\u7528\u667a\u6167\u4e14\u8996\u89ba\u5316\u7684\u81e8\u5e8a\u6c7a\u7b56\u652f\u63f4\u7cfb\u7d71\uff0c\u53ef\u4ee5\u5354\u52a9\u85e5\u5e2b\u57f7\u884c\u7528\u85e5\u5be9\u67e5\u3002\u6211\u5011\u7684\u89c0\u9ede\u4e3b\u8981\u662f\u9a57\u8b49\u7cfb\u7d71\u5728\u81e8\u5e8a\u689d\u4ef6\u4e0b\u7684\u6548\u5ea6\u3002</paragraph>", "author": "Abdelmalek Mouazer et.al.", "authors": "Abdelmalek Mouazer, Sophie Dubois, Romain L\u00e9guillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte S\u00e9roussi, Julien Grosjean, Romain Lelong, Catherine Letord, St\u00e9fan Darmoni, Karima Sedki, Pierre Meneton, Rosy Tsopra, Hector Falcoff, Jean-Baptiste Lamy", "id": "2409.01903v1", "paper_url": "http://arxiv.org/abs/2409.01903v1", "repo": "null"}}